perrigo co. plc - PRGO

PRGO

Close Chg Chg %
28.92 -0.49 -1.68%

Closed Market

28.43

-0.49 (1.68%)

Volume: 1.35M

Last Updated:

Dec 5, 2024, 3:59 PM EDT

Company Overview: perrigo co. plc - PRGO

PRGO Key Data

Open

$28.87

Day Range

28.32 - 28.96

52 Week Range

23.89 - 34.60

Market Cap

$3.94B

Shares Outstanding

136.43M

Public Float

135.87M

Beta

0.52

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.11

Yield

381.88%

Dividend

$0.28

EX-DIVIDEND DATE

Nov 29, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

1.60M

 

PRGO Performance

1 Week
 
1.30%
 
1 Month
 
9.67%
 
3 Months
 
4.41%
 
1 Year
 
-2.50%
 
5 Years
 
-44.71%
 

PRGO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About perrigo co. plc - PRGO

Perrigo Co. Plc engages in the provision of self-care products and over the counter health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The Consumer Self-Care International segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

PRGO At a Glance

Perrigo Co. Plc
The Sharp Building
Dublin, Dublin 2
Phone 353-1-709-4000 Revenue 4.66B
Industry Pharmaceuticals: Major Net Income -12,700,000.00
Sector Health Technology 2023 Sales Growth 4.597%
Fiscal Year-end 12 / 2024 Employees 9,140
View SEC Filings

PRGO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.935
Price to Book Ratio 0.915
Price to Cash Flow Ratio 10.737
Enterprise Value to EBITDA 12.253
Enterprise Value to Sales 1.689
Total Debt to Enterprise Value 0.542

PRGO Efficiency

Revenue/Employee 509,310.722
Income Per Employee -1,389.497
Receivables Turnover 6.061
Total Asset Turnover 0.427

PRGO Liquidity

Current Ratio 1.786
Quick Ratio 1.067
Cash Ratio 0.474

PRGO Profitability

Gross Margin 36.074
Operating Margin 6.062
Pretax Margin -0.178
Net Margin -0.273
Return on Assets -0.04
Return on Equity -0.092
Return on Total Capital -0.049
Return on Invested Capital -0.05

PRGO Capital Structure

Total Debt to Total Equity 89.358
Total Debt to Total Capital 47.19
Total Debt to Total Assets 39.416
Long-Term Debt to Equity 79.54
Long-Term Debt to Total Capital 42.005
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Perrigo Co. Plc - PRGO

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
5.06B 4.14B 4.45B 4.66B
Sales Growth
+4.67% -18.21% +7.47% +4.60%
Cost of Goods Sold (COGS) incl D&A
3.25B 2.72B 2.99B 2.98B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
384.80M 312.20M 338.60M 359.50M
Depreciation
90.10M 102.20M 86.20M 93.70M
Amortization of Intangibles
294.70M 210.00M 252.40M 265.80M
COGS Growth
+6.18% -16.24% +9.82% -0.51%
Gross Income
1.81B 1.42B 1.46B 1.68B
Gross Income Growth
+2.06% -21.73% +2.96% +15.08%
Gross Profit Margin
+35.77% +34.23% +32.79% +36.07%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.35B 1.19B 1.29B 1.40B
Research & Development
177.70M 122.00M 123.10M 122.50M
Other SG&A
1.17B 1.07B 1.16B 1.27B
SGA Growth
+0.81% -11.58% +7.86% +8.61%
Other Operating Expense
- - - -
-
Unusual Expense
369.50M 177.60M 140.40M 97.30M
EBIT after Unusual Expense
92.60M 47.20M 32.60M 184.90M
Non Operating Income/Expense
(100.00M) 332.00M (26.40M) 31.50M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
3.00M (1.10M) (1.50M) (1.90M)
Interest Expense
142.00M 120.50M 145.30M 224.70M
Interest Expense Growth
+12.25% -15.14% +20.58% +54.65%
Gross Interest Expense
142.00M 120.50M 145.30M 224.70M
Interest Capitalized
- - - -
-
Pretax Income
(149.40M) 258.70M (139.10M) (8.30M)
Pretax Income Growth
-187.37% +273.16% -153.77% +94.03%
Pretax Margin
-2.95% +6.25% -3.13% -0.18%
Income Tax
13.20M 389.60M (8.20M) (3.90M)
Income Tax - Current - Domestic
20.30M 14.90M (7.80M) 18.20M
Income Tax - Current - Foreign
47.40M 384.90M 33.60M 58.60M
Income Tax - Deferred - Domestic
(52.40M) 3.30M (8.60M) (12.90M)
Income Tax - Deferred - Foreign
(2.10M) (13.50M) (25.40M) (67.80M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
3.00M (1.10M) (1.50M) (1.90M)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(162.60M) (130.90M) (130.90M) (4.40M)
Minority Interest Expense
- - - -
-
Net Income
(162.60M) (130.90M) (130.90M) (4.40M)
Net Income Growth
- -211.29% +19.50% +96.64%
Net Margin Growth
-3.21% -3.16% -2.94% -0.09%
Extraordinaries & Discontinued Operations
- 14.50M (9.70M) (8.30M)
Discontinued Operations
- 14.50M (9.70M) (8.30M)
Net Income After Extraordinaries
(162.60M) (116.40M) (140.60M) (12.70M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(162.60M) (116.40M) (140.60M) (12.70M)
EPS (Basic)
-1.1947 -0.8713 -1.0454 -0.0939
EPS (Basic) Growth
-211.21% +27.07% -19.98% +91.02%
Basic Shares Outstanding
136.10M 133.60M 134.50M 135.30M
EPS (Diluted)
-1.1947 -0.8713 -1.0454 -0.0939
EPS (Diluted) Growth
-211.62% +27.07% -19.98% +91.02%
Diluted Shares Outstanding
136.10M 133.60M 134.50M 135.30M
EBITDA
846.90M 537.00M 511.60M 641.70M
EBITDA Growth
+1.68% -36.59% -4.73% +25.43%
EBITDA Margin
+16.73% +12.97% +11.50% +13.78%

Snapshot

Average Recommendation BUY Average Target Price 36.25
Number of Ratings 7 Current Quarters Estimate 0.947
FY Report Date 12 / 2024 Current Year's Estimate 2.595
Last Quarter’s Earnings 0.81 Median PE on CY Estimate N/A
Year Ago Earnings 2.58 Next Fiscal Year Estimate 3.106
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 3 5 5
Mean Estimate 0.95 0.70 2.59 3.11
High Estimates 1.02 0.74 2.65 3.25
Low Estimate 0.89 0.67 2.53 3.04
Coefficient of Variance 5.72 5.05 1.89 2.73

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 1 1 1
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Perrigo Co. Plc - PRGO

Date Name Shares Transaction Value
Jul 11, 2024 Patrick Lockwood-Taylor CEO; Director 37,852 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.16 per share 1,028,060.32
Jul 11, 2024 Patrick Lockwood-Taylor CEO; Director 48,826 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $27.16 per share 1,326,114.16
Jul 11, 2024 Patrick Lockwood-Taylor CEO; Director 49,689 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $27.16 per share 1,349,553.24
Jul 11, 2024 Patrick Lockwood-Taylor CEO; Director 45,409 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.16 per share 1,233,308.44
Jul 11, 2024 Patrick Lockwood-Taylor CEO; Director 56,651 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 12, 2024 Eduardo Guarita Bezerra EVP & Chief Financial Officer 4,531 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 12, 2024 Eduardo Guarita Bezerra EVP & Chief Financial Officer 15,459 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $26.94 per share 416,465.46
Jun 12, 2024 Eduardo Guarita Bezerra EVP & Chief Financial Officer 16,563 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $26.94 per share 446,207.22
Jun 12, 2024 Todd W. Kingma Executive VP, General Counsel 21,715 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Orlando D. Ashford Director 15,733 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 475,451.26
May 17, 2024 Bradley A. Alford Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Bradley A. Alford Director 9,904 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Jeffrey B. Kindler Director 23,007 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 695,271.54
May 17, 2024 Jeffrey B. Kindler Director 27,214 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 822,407.08
May 17, 2024 Orlando D. Ashford Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Orlando D. Ashford Director 12,380 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Orlando D. Ashford Director 20,992 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 634,378.24
May 17, 2024 Geoffrey M. Parker Director 20,262 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 612,317.64
May 17, 2024 Geoffrey M. Parker Director 9,904 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Geoffrey M. Parker Director 24,469 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $30.22 per share 739,453.18

Perrigo Co. Plc in the News